Home
>
National Drug Code (NDC)
>
Deprizine
Deprizine - 43093-102-01 - (Ranitidine Hydrochloride)
Drug Information of Deprizine
| Product NDC: | 43093-102 |
| Proprietary Name: | Deprizine |
| Non Proprietary Name: | Ranitidine Hydrochloride |
| Active Ingredient(s): | & nbsp; Ranitidine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Deprizine
| Product NDC: | 43093-102 |
| Labeler Name: | Fusion Pharmaceuticals LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20100208 |
Package Information of Deprizine
| Package NDC: | 43093-102-01 |
| Package Description: | 1 KIT in 1 KIT (43093-102-01) * 4.2 g in 1 BOTTLE, GLASS * 250 mL in 1 BOTTLE, PLASTIC |
NDC Information of Deprizine
| NDC Code | 43093-102-01 |
| Proprietary Name | Deprizine |
| Package Description | 1 KIT in 1 KIT (43093-102-01) * 4.2 g in 1 BOTTLE, GLASS * 250 mL in 1 BOTTLE, PLASTIC |
| Product NDC | 43093-102 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ranitidine Hydrochloride |
| Dosage Form Name | KIT |
| Route Name | ORAL |
| Start Marketing Date | 20100208 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Fusion Pharmaceuticals LLC |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
